Ana Abellan-Tapia
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
NLRP6 as a candidate segmental barrier to carcinogenesis in the human gut: a hypothesis.
Journal: Frontiers in immunology
Published: March 04, 2026
Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review.
Journal: Frontiers in immunology
Published: April 21, 2025
Non-decameric NLRP3 reveals a TGN/MTOC-distal pathway of inflammasome activation.
Journal: Nature communications
Published: July 23, 2024
Measuring NLR Oligomerization III: Detection of NLRP3 and NLRC4 Complex by Bioluminescence Resonance Energy Transfer.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 14, 2023
Addendum: MCC950 closes the active conformation of NLRP3 to an inactive state.
Journal: Nature chemical biology
Published: January 26, 2021
Author Correction: Early endosome autoantigen 1 regulates IL-1β release upon caspase-1 activation independently of gasdermin D membrane permeabilization.
Journal: Scientific reports
Published: December 02, 2020
ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux.
Journal: The Journal of cell biology
Published: March 09, 2020
Isolation of functional mature peritoneal macrophages from healthy humans.
Journal: Immunology and cell biology
Published: July 05, 2019
Early endosome autoantigen 1 regulates IL-1β release upon caspase-1 activation independently of gasdermin D membrane permeabilization.
Journal: Scientific reports
Published: September 20, 2018
MCC950 closes the active conformation of NLRP3 to an inactive state.
Journal: Nature chemical biology
Published: July 09, 2018
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway.
Journal: Nature communications
Published: January 30, 2018
Last Updated: 09/26/2026